This site is intended for health professionals only

Home
>
Reviews & Research

Reviews & Research

Cancer Research UK tests first of its kind vaccine to treat lung cancer

Cancer Research UK tests first of its kind vaccine to treat lung cancer

£18 million fund to tackle six biggest themes in brain tumour research launched

£18 million fund to tackle six biggest themes in brain tumour research launched

Landmark IMPACT study published in New England Journal of Medicine

Landmark IMPACT study published in New England Journal of Medicine

Erenumab can help reduce episodic migraines, research has found

Erenumab can help reduce episodic migraines, research has found

Researchers discover 40 genes involved in early development of myeloma

Researchers discover 40 genes involved in early development of myeloma

Ensuring patient access to medical research after Brexit

Ensuring patient access to medical research after Brexit

New potential drug target for common but deadly parasitic disease found

New potential drug target for common but deadly parasitic disease found

Largest clinical trial ever conducted in postpartum haemorrhage completed

Largest clinical trial ever conducted in postpartum haemorrhage completed

New England Journal of Medicine publishes nusinersen Phase III CHERISH study results

New England Journal of Medicine publishes nusinersen Phase III CHERISH study results

Cancer Research UK to invest £45 million in clinical trials

Cancer Research UK to invest £45 million in clinical trials

NICE Final Appraisal Determination recommends use of brodalumab as cost-effective

NICE Final Appraisal Determination recommends use of brodalumab as cost-effective

CAR T-cell therapy: managing side effects

CAR T-cell therapy: managing side effects

« Previous 1 … 6 7 8 9 10 … 37 Next »

Most read

1

Oral vitamin A could become an alternative to isotretinoin for acne

2

Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan

3

Amino acids supplement reduces muscle wasting and improves gut function in critically ill

4

Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest

5

Launch of the new Hospital Pharmacy Europe Mobile App

Be in the know

Subscribe to Hospital Pharmacy Europe newsletter and magazine

Subscribe

x